Biological treatment of ankylosing spondylitis: a nationwide study of treatment trajectories on a patient level in clinical practice
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6362
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Biological treatment of ankylosing spondylitis: a nationwide study of treatment trajectories on a patient level in clinical practice ; volume:21 ; number:1 ; day:28 ; month:5 ; year:2019 ; pages:1-10 ; date:12.2019
Arthritis Research & Therapy ; 21, Heft 1 (28.5.2019), 1-10, 12.2019
- Creator
-
Lindström, Ulf
Olofsson, Tor
Wedrén, Sara
Qirjazo, Ilia
Askling, Johan
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13075-019-1908-9
- URN
-
urn:nbn:de:101:1-2019112405571507394923
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lindström, Ulf
- Olofsson, Tor
- Wedrén, Sara
- Qirjazo, Ilia
- Askling, Johan
- SpringerLink (Online service)
Other Objects (12)
Surgical treatment of ankylosing spondylitis deformity
Interleukin-17 inhibitors for the treatment of ankylosing spondylitis
Impact of ankylosing spondylitis on depression: a nationwide cohort study
LINC00311 is overexpressed in ankylosing spondylitis and predict treatment outcomes and recurrence
Andersson lesion in ankylosing spondylitis
Comparative Pharmacoeconomic Effectiveness of Interleukin-17 Inhibitors for the Treatment of Ankylosing Spondylitis
Research Progress on Molecular Mechanism of Moxibustion in the Treatment of Ankylosing Spondylitis
Clinical and Economic Benefit of Advanced Therapies for the Treatment of Active Ankylosing Spondylitis
The surgical treatment strategies for thoracolumbar spine fractures with ankylosing spondylitis: a case report
Cost Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK
Secukinumab: A Review in Ankylosing Spondylitis
Erratum to: Comparative Pharmacoeconomic Effectiveness of Interleukin-17 Inhibitors for the Treatment of Ankylosing Spondylitis
Surgical treatment of ankylosing spondylitis deformity
Interleukin-17 inhibitors for the treatment of ankylosing spondylitis
Impact of ankylosing spondylitis on depression: a nationwide cohort study
LINC00311 is overexpressed in ankylosing spondylitis and predict treatment outcomes and recurrence
Andersson lesion in ankylosing spondylitis
Comparative Pharmacoeconomic Effectiveness of Interleukin-17 Inhibitors for the Treatment of Ankylosing Spondylitis
Research Progress on Molecular Mechanism of Moxibustion in the Treatment of Ankylosing Spondylitis
Clinical and Economic Benefit of Advanced Therapies for the Treatment of Active Ankylosing Spondylitis
The surgical treatment strategies for thoracolumbar spine fractures with ankylosing spondylitis: a case report
Cost Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK
Secukinumab: A Review in Ankylosing Spondylitis
Erratum to: Comparative Pharmacoeconomic Effectiveness of Interleukin-17 Inhibitors for the Treatment of Ankylosing Spondylitis
Surgical treatment of ankylosing spondylitis deformity
Interleukin-17 inhibitors for the treatment of ankylosing spondylitis
Impact of ankylosing spondylitis on depression: a nationwide cohort study
LINC00311 is overexpressed in ankylosing spondylitis and predict treatment outcomes and recurrence
Andersson lesion in ankylosing spondylitis
Comparative Pharmacoeconomic Effectiveness of Interleukin-17 Inhibitors for the Treatment of Ankylosing Spondylitis
Research Progress on Molecular Mechanism of Moxibustion in the Treatment of Ankylosing Spondylitis
Clinical and Economic Benefit of Advanced Therapies for the Treatment of Active Ankylosing Spondylitis
The surgical treatment strategies for thoracolumbar spine fractures with ankylosing spondylitis: a case report
Cost Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK
Secukinumab: A Review in Ankylosing Spondylitis